Stanford type B aortic dissection involves a tear in the descending aorta (distal to the left subclavian artery) without involvement of the ascending aorta. It is classified as uncomplicated (managed medically) or complicated (requiring intervention), a distinction that drives all management decisions. [1-2] Approximately 25–40% of initially uncomplicated cases will progress to complicated disease. [3-4]
The following figure from a 2025 NEJM review illustrates the management algorithm for type B aortic dissection:
1. History
- Onset and character of pain: Abrupt/instantaneous onset of severe chest, back, or abdominal pain — classically described as "sharp," "stabbing," "tearing," or "ripping" and maximal at onset [2][6]
- Type B dissection most commonly presents with back pain (64%), followed by chest pain (63%) and abdominal pain (43%) [6]
- Pain may migrate as the dissection propagates distally
- Ask about symptoms of malperfusion: leg pain/weakness, abdominal pain, decreased urine output, neurologic deficits [2]
- Timing: Classify as hyperacute (<24 h), acute (1–14 days), subacute (15–90 days), or chronic (>90 days) [4]
- Precipitating events: exertion, emotional stress, cocaine/stimulant use, recent aortic manipulation [1][6]
- Important negatives: absence of syncope, dyspnea, hemoptysis
2. Alarm Features
- Malperfusion syndrome: limb ischemia, mesenteric ischemia (abdominal pain out of proportion), renal failure (oliguria/hematuria), paraplegia (spinal cord ischemia) [1-2]
- Signs of rupture/impending rupture: hemodynamic instability, hypotension/shock, hemothorax, increasing periaortic/mediastinal hematoma on serial imaging [1][7]
- Refractory pain despite adequate analgesia and BP control [1][4]
- Refractory hypertension despite maximal medical therapy [1][4]
- Rapid aortic expansion on serial imaging [7]
- Any of the above reclassifies the dissection as complicated and warrants urgent intervention [2][4]
3. Medications
- First-line acute: IV beta-blockers (esmolol, labetalol) to target SBP 100–120 mmHg and HR 60–80 bpm [3-5]
- If beta-blockers insufficient: add IV vasodilators (nicardipine, nitroprusside — only after adequate beta-blockade to prevent reflex tachycardia) [3]
- Analgesia: IV opioids for pain control; pain drives sympathetic activation and worsens hemodynamics [3]
- Transition to oral: beta-blockers, ACE inhibitors/ARBs, and calcium channel blockers for lifelong BP control (target ≤120/80 mmHg) [4][8]
- Contraindicated/caution: Avoid anticoagulation and thrombolytics unless clearly indicated for another reason — risk of catastrophic hemorrhage. Avoid nitroprusside without prior beta-blockade [3]
- Fluoroquinolones have been associated with increased risk of aortic events and should be used with caution [1]
4. Diet
- Sodium restriction to support long-term BP control
- Adequate hydration, but avoid volume overload
- Smoking cessation is critical — smoking accelerates aneurysmal degeneration [9]
- Avoid excessive caffeine and stimulants
- Long-term: heart-healthy diet, statin therapy for dyslipidemia (target LDL <70 mg/dL is reasonable) [9]
5. Review of Systems
- Cardiovascular: chest/back/abdominal pain, palpitations, syncope, limb pain or coolness
- GI: abdominal pain, nausea/vomiting, bloody stools (mesenteric malperfusion)
- Renal: decreased urine output, hematuria
- Neurologic: lower extremity weakness/numbness (spinal cord ischemia), focal deficits
- Respiratory: dyspnea, hemoptysis (rupture into lung parenchyma)
- Constitutional: diaphoresis, sense of impending doom
6. Collateral History and Family History
- Family history of thoracic aortic aneurysm, dissection, or unexplained sudden death — present in 13–19% of non-syndromic cases [6]
- Known connective tissue disorders: Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, Turner syndrome [6]
- Genetic mutations: FBN1, TGFBR1/2, ACTA2, MYH11 [6]
- Social history: cocaine/amphetamine use, smoking, weightlifting [6][10]
- Prior aortic surgery or catheter-based procedures [6]
7. Risk Factors
- Hypertension (present in up to 75% of cases — the single most prevalent risk factor) [5][10]
- Male sex, mean age ~63 years [5]
- Smoking [10]
- Cocaine/amphetamine use [6][11]
- Connective tissue disorders (Marfan, Loeys-Dietz, vascular Ehlers-Danlos) [6]
- Bicuspid aortic valve, coarctation of the aorta [6]
- Pre-existing thoracic aortic aneurysm [1]
- Prior cardiac surgery [11]
- Black race (more likely to present with type B, younger age, higher rates of hypertension) [1]
- Inflammatory vasculitides (Takayasu, giant cell arteritis) [6]
- Pregnancy (type B more common postpartum) [1]
8. Differential Diagnosis
- Acute coronary syndrome — the most common misdiagnosis; distinguished by ECG/troponin/D-dimer pattern (see ECG section) [7]
- Pulmonary embolism — pleuritic pain, dyspnea; D-dimer elevated in both; CTA differentiates [7]
- Tension pneumothorax — unilateral breath sounds, tracheal deviation
- Pericarditis/myocarditis — diffuse ST elevation, positional pain
- Esophageal rupture (Boerhaave syndrome) — post-emesis, subcutaneous emphysema
- Musculoskeletal pain — reproducible on palpation, no hemodynamic changes
- Intramural hematoma / penetrating aortic ulcer — variants of acute aortic syndrome, distinguished on CTA [2]
- Mesenteric ischemia — if presenting with isolated abdominal pain
9. Past Medical History
- Prior aortic dissection or aneurysm
- Known aortic valve disease (bicuspid aortic valve)
- History of connective tissue disorder
- Chronic hypertension and medication compliance
- Prior cardiac or aortic surgery
- Chronic kidney disease (affects contrast use and BP management)
- Atherosclerotic disease
10. Physical Exam
- Vital signs: Hypertension is common at presentation; hypotension suggests rupture or tamponade. Check bilateral arm BPs — asymmetry >20 mmHg suggests branch vessel compromise [2][6]
- Pulse exam: Check all four extremities for pulse deficits [6]
- Cardiac: New diastolic murmur (aortic regurgitation — more common in type A but can occur with retrograde extension)
- Abdominal: Tenderness (mesenteric ischemia), pulsatile mass
- Neurologic: Lower extremity motor/sensory deficits (paraplegia from spinal malperfusion) [2]
- Extremities: Cool, mottled, or pulseless limb (iliac malperfusion) [2]
- Skin: Marfanoid habitus, striae, joint hypermobility (connective tissue disease clues)
11. Lab Studies
- D-dimer: High sensitivity (~94%) for acute aortic dissection; a negative D-dimer (<500 ng/mL) in a low-risk patient effectively rules out AAS. Values >1,600 ng/mL strongly suggest AAS [2][7][12]
- Troponin: Usually normal in type B; if elevated, consider coronary malperfusion or demand ischemia. Troponin positivity does not rule out dissection [7]
- CBC, BMP, lactate: Assess for malperfusion (elevated lactate, creatinine, metabolic acidosis)
- Type and screen / crossmatch: Prepare for potential intervention
- Coagulation studies: PT/INR, PTT, fibrinogen
- LFTs, lipase: If mesenteric malperfusion suspected
- Urinalysis: Hematuria suggests renal malperfusion
The triad of normal ECG + normal troponin + elevated D-dimer is a strong alerting pattern for AAS and makes ACS unlikely. [7]
12. Imaging
- First-line / Gold standard: CT angiography (CTA) of the chest, abdomen, and pelvis — sensitivity and specificity approaching 100%. Should include non-contrast phase first (to detect intramural hematoma) followed by contrast-enhanced images [2][7][13-14]
- Chest X-ray: Not diagnostic but may show widened mediastinum, abnormal aortic contour, pleural effusion (left-sided). Normal CXR does not exclude dissection (~40% lack widened mediastinum) [6]
- TEE: Alternative when CT unavailable or patient too unstable; excellent for proximal aorta [13]
- MRI: High accuracy but limited by acquisition time; useful for surveillance and follow-up to reduce radiation [2]
- TTE (bedside echo): Can detect intimal flap, aortic regurgitation, pericardial effusion; sensitivity lower than CTA but useful as rapid bedside screen [13][15]
Key CTA findings: intimal flap separating true and false lumens, entry tear location, extent of dissection, branch vessel involvement, malperfusion signs, aortic diameter, false lumen thrombosis status [7]
13. Special Tests
- Aortic Dissection Detection Risk Score (ADD-RS): Stratifies pretest probability using 12 high-risk features across 3 categories (predisposing conditions, pain features, exam findings). ADD-RS ≤1 combined with D-dimer <500 ng/mL has sensitivity up to 98–99% for ruling out AAS [1][16]
- Point-of-care ultrasound (POCUS): Abdominal aorta assessment for flap; focused cardiac echo for pericardial effusion and aortic regurgitation [15]
- Intravascular ultrasound (IVUS): Used intraoperatively during TEVAR for real-time assessment
14. ECG
- ECG is primarily used to rule out ACS, not to diagnose dissection [15]
- In type B dissection, ECG is often normal or shows nonspecific ST-T changes, LVH from chronic hypertension
- ECG evidence of ischemia present in up to 19% of all acute aortic dissections (more common in type A with coronary involvement) [6][12]
- Dangerous pattern to recognize: ST elevation mimicking STEMI — if dissection is suspected, CTA before cath lab to avoid catastrophic anticoagulation/thrombolysis [6]
- The combination of STEMI pattern + severe back pain + pulse deficit should raise immediate concern for dissection rather than primary ACS
15. Assessment
Severity stratification is the cornerstone of management
- Uncomplicated type B: No malperfusion, no rupture, pain controlled, BP responsive to medical therapy. In-hospital mortality 1–10% [3][17]
- Complicated type B: Malperfusion, rupture/impending rupture, refractory pain, refractory hypertension, rapid expansion. Early mortality ~16% [3]
- High-risk features (even if currently uncomplicated): Aortic diameter >40–44 mm, false lumen diameter >22 mm, entry tear >10 mm, entry tear on lesser curvature, entry tear <20 mm from left subclavian artery [4][7][15]
Approximately 25–30% of uncomplicated cases progress to complicated disease, and aneurysmal degeneration rates exceed 70% at 3–5 years. [4]
16. Treatment Plan
Uncomplicated Type B — Medical Management (First-Line): [2-5]
- ICU admission for hemodynamic monitoring
- IV esmolol (titrate to HR 60–80 bpm, SBP 100–120 mmHg) or IV labetalol
- Add nicardipine or nitroprusside if BP remains above target (only after beta-blockade)
- IV opioids (morphine/fentanyl) for pain control
- Transition to oral antihypertensives when tolerating PO: beta-blocker + ACE inhibitor/ARB ± CCB. Target BP ≤120/80 mmHg lifelong [4]
- Statin therapy, smoking cessation [9]
Complicated Type B — Intervention: [2][4-5]
- TEVAR is the treatment of choice for complicated TBAD with suitable anatomy (Class I recommendation) [2][4]
- Open surgical repair if anatomy unsuitable for TEVAR [4]
- Adjunctive procedures: branch vessel stenting, fenestration for persistent malperfusion [5]
Uncomplicated with High-Risk Features: [2][15]
- Prophylactic TEVAR may be considered (Class IIb) to reduce late aortic events [2]
- INSTEAD-XL showed improved 5-year aorta-specific survival with TEVAR + medical therapy vs. medical therapy alone (6.9% vs. 19.3% aortic-specific mortality) [5]
17. Disposition
- All acute type B dissections require ICU admission for hemodynamic monitoring, serial exams, and pain management [5]
- Admission criteria: Any confirmed or suspected acute aortic dissection
- Surgical/interventional consultation triggers: Any signs of complication (malperfusion, rupture, refractory pain/HTN), high-risk morphologic features on CTA [2][4]
- Discharge criteria: Pain controlled on oral medications, BP at goal on oral regimen, stable serial imaging, no evidence of malperfusion, clear follow-up plan [5]
- Vascular surgery or cardiothoracic surgery should be consulted on all cases at presentation
18. Follow-Up / Return Precautions
Surveillance imaging protocol (2022 ACC/AHA, Class I): [2][5]
- CTA (or MRI) at 1 month, 6 months, and 12 months after diagnosis, then annually if stable
- Intervention warranted during follow-up if: total aortic diameter increases ≥5 mm in 6 months, ≥10 mm in 1 year, or reaches ≥55 mm [5]
Lifelong management: [1][4]
- Strict BP control (≤120/80 mmHg) with beta-blocker–based regimen
- Compliance with medications — median of 4 antihypertensive agents often required [18]
- Avoid intense static exercise, heavy weightlifting, Valsalva maneuvers, and collision sports [15]
- Mild-to-moderate dynamic exercise (30–60 min, 3–4 days/week) is recommended [15]
Return precautions — seek immediate care for
- New or worsening chest, back, or abdominal pain
- Leg pain, weakness, or color change
- Decreased urine output
- Syncope or near-syncope
- Any new neurologic symptoms
~50% of patients are lost to follow-up by 28 months, and 38% of medically managed patients develop complications requiring intervention — emphasizing the critical importance of adherence to surveillance. [1]
References
1. Acute Aortic Dissection. — Carrel T, Sundt TM, von Kodolitsch Y, Czerny M. Lancet. 2023.
2. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. — Isselbacher EM, Preventza O, Hamilton Black Iii J, et al. Journal of the American College of Cardiology. 2022.
3. Optimal Treatment of Uncomplicated Type B Aortic Dissection: JACC Review Topic of The Week. — Tadros RO, Tang GHL, Barnes HJ, et al. Journal of the American College of Cardiology. 2019.
4. The Society of Thoracic Surgeons/American Association for Thoracic Surgery Clinical Practice Guidelines on the Management of Type B Aortic Dissection. — MacGillivray TE, Gleason TG, Patel HJ, et al. The Annals of Thoracic Surgery. 2022.
5. Management of Acute Type B Aortic Dissection. — Mussa FF, Kougias P. The New England Journal of Medicine. 2025.
6. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology,American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. — Hiratzka LF, Bakris GL, Beckman JA, et al. Journal of the American College of Cardiology. 2010.
7. Acute Aortic Syndrome Revisited: JACC State-of-the-Art Review. — Vilacosta I, San Román JA, di Bartolomeo R, et al. Journal of the American College of Cardiology. 2021.
8. Hypertension in Thoracic Aortic Dissection: A Meta-Analysis-Based Considerations in the Choice of Antihypertensive Agents. — Sharma S, Seth J, Rabkin SW. American Journal of Hypertension. 2025.
9. The Society for Vascular Surgery’s Multidisciplinary Management Guide on the Perioperative Care of Patients with Vascular Disease. — Rabih Chaer MD MS, Cassius Iyad Ochoa Chaar MD MS, Theodore Yuo MD, et al Society for Vascular Surgery (2023). 2023.
10. Management of Acute Aortic Dissection. — Nienaber CA, Clough RE. Lancet. 2015.
11. Thoracic Aortic Aneurysm and Dissection. — Goldfinger JZ, Halperin JL, Marin ML, et al. Journal of the American College of Cardiology. 2014.
12. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. — Hiratzka LF, Bakris GL, Beckman JA, et al. Circulation. 2010.
13. Acute Aortic Dissection and Intramural Hematoma: A Systematic Review. — Mussa FF, Horton JD, Moridzadeh R, et al. The Journal of the American Medical Association. 2016.
14. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. — Gulati M, Levy PD, Mukherjee D, et al. Journal of the American College of Cardiology. 2021.
15. EACTS/STS Guidelines for Diagnosing and Treating Acute and Chronic Syndromes of the Aortic Organ. — Czerny M, Grabenwöger M, Berger T, et al. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery. 2024.
16. Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Alone or With D-Dimer for Acute Aortic Syndromes: Systematic Review and Meta-Analysis. — Ren S, Essat M, Pandor A, et al. PloS One. 2023.
17. ACR Appropriateness Criteria® Thoracic Aortic Aneurysm or Dissection-Treatment Planning and Follow-Up: 2024 Update. — Ripley B, Scheidt MJ, Aghayev A, et al. Journal of the American College of Radiology : JACR. 2025.
18. First-Line Beta-Blockers Versus Other Antihypertensive Medications for Chronic Type B Aortic Dissection. — Chan KK, Lai P, Wright JM. The Cochrane Database of Systematic Reviews. 2014.